Crohn's Disease and the Paleo Ketogenic Diet
Introduction
Crohn's disease is often considered a lifelong condition. Most patients experience periods of remission and relapse, and treatment typically focuses on controlling inflammation, reducing symptoms, and preventing complications rather than achieving a cure.(Mayo Clinic)
This is why a 2016 case report published by researchers from Paleomedicina attracted significant attention.
The report described a 14-year-old patient with severe Crohn's disease who experienced resolution of symptoms, normalization of laboratory markers, improvement on imaging studies, and normalization of a test of intestinal permeability while following the Paleolithic Ketogenic Diet (PKD). According to the report, the patient was able to discontinue medication within two weeks of starting the dietary intervention.
For supporters of the Paleo Ketogenic Diet, this case represents evidence that dietary therapy may address fundamental mechanisms driving inflammatory bowel disease. For critics, it represents an interesting observation that requires validation through larger and more rigorous studies.
Regardless of where one stands, the case raises important questions about the relationship between nutrition, intestinal permeability, immune activation, and chronic inflammation.
In this article, you'll learn what happened in this widely discussed Crohn's disease case, the physiological mechanisms proposed by the authors, and what conclusions can—and cannot—be drawn from a single case report.
The Patient's Story
The case involved a 14-year-old boy with severe Crohn's disease. Before starting the Paleolithic Ketogenic Diet, he experienced symptoms typical of active inflammatory bowel disease, including abdominal complaints and evidence of ongoing intestinal inflammation. Conventional medical therapy had produced limited success, and the disease remained active despite treatment.
After consultation with the Paleomedicina team, the patient began a strict Paleolithic Ketogenic Diet consisting primarily of animal fat, meat, organ meats, and eggs while excluding grains, legumes, dairy products, vegetable oils, processed foods, and most plant foods. The diet was implemented as a therapeutic intervention rather than a weight-loss strategy.
According to the published report, the response was rapid. Symptoms improved significantly, and the patient was able to discontinue medication within two weeks of starting the dietary protocol. Laboratory markers normalized, and follow-up evaluations suggested progressive improvement in intestinal inflammation. The authors also reported normalization of a polyethylene glycol (PEG 400) intestinal permeability test, which they interpreted as evidence of restoration of intestinal barrier function.
Perhaps the most important aspect of the case was that the improvement was not based solely on symptom relief. The report described objective changes, including normalization of laboratory parameters and imaging findings consistent with reduced bowel inflammation. This is one reason the case attracted attention among both supporters and critics of dietary therapy.
For the Paleomedicina group, this case served as a practical example of their broader hypothesis: that addressing intestinal permeability and metabolic dysfunction through a strict animal-based ketogenic diet may allow chronic inflammatory diseases to improve in ways that extend beyond symptom management. Whether this represents a unique response in a single patient or evidence of a more broadly applicable therapeutic approach remains one of the central questions raised by the report.
The Mechanism Proposed by the Authors
What made this case report particularly interesting was not only the clinical improvement, but the explanation proposed by the authors for why it occurred.
The Paleomedicina group argues that Crohn's disease is not simply a disorder of excessive immune activity. Instead, they propose that a key driver of the disease is intestinal barrier dysfunction, often referred to as increased intestinal permeability. According to their model, a compromised intestinal barrier allows substances from the gut to enter circulation more readily, promoting chronic immune activation and inflammation.
In this framework, the Paleo Ketogenic Diet is intended to address the upstream problem rather than suppress downstream inflammation.
The authors point to one particularly important finding in the case: normalization of the PEG 400 intestinal permeability test. This occurred alongside symptom resolution, normalization of laboratory markers, and improvement in bowel inflammation on imaging studies. They interpreted this as evidence that restoration of intestinal barrier function may have played a central role in the patient's recovery.
Another important aspect of their hypothesis involves the exclusion of dairy products. Unlike many ketogenic diets, the Paleo Ketogenic Diet removes dairy completely. The authors suggest that certain dietary components may continue to affect intestinal permeability even when carbohydrate intake is very low and ketosis is achieved.
From a metabolic perspective, the diet may also influence several pathways already known to be involved in Crohn's disease:
Lower insulin levels
Reduced glucose fluctuations
Nutritional ketosis
Changes in inflammatory signaling
Elimination of ultra-processed foods
This creates an important question: was the improvement driven primarily by restoration of intestinal barrier function, by ketosis, by removal of processed foods, or by some combination of all these factors?
The case report cannot answer that question definitively.
What it does provide is a clinical observation that challenges researchers to investigate these mechanisms further. The remarkable outcome reported in this patient suggests that dietary interventions may influence disease activity in ways that are not yet fully understood, but larger controlled studies would be needed to determine which mechanisms are most important and how reproducible these results truly are.
The Evolutionary Argument Behind the Diet
The Paleomedicina group does not view the Paleo Ketogenic Diet as simply another elimination diet.
According to their model, the therapeutic effects of the diet arise because it more closely resembles the foods that shaped human physiology throughout evolution.
Their argument is that many foods commonly consumed today were introduced relatively recently in human history. Agriculture, dairy farming, industrial food processing, refined vegetable oils, and modern food additives represent a very small fraction of the time humans have existed as a species.
From this perspective, the human digestive and immune systems evolved primarily in the context of animal-based foods.
The authors propose that chronic exposure to evolutionarily novel foods may contribute to:
Increased intestinal permeability
Chronic immune activation
Systemic inflammation
Metabolic dysfunction
In this framework, Crohn's disease is not simply a disease that requires suppression of inflammation. It is a disease driven by ongoing exposure to factors that disrupt normal physiology.
The goal of the Paleo Ketogenic Diet is therefore not merely symptom management. It is an attempt to remove the underlying triggers that maintain intestinal barrier dysfunction and chronic inflammation.
This is one reason the protocol excludes foods that are often allowed on conventional ketogenic diets, including dairy products, nuts, seeds, and many plant foods. The authors argue that ketosis alone is not sufficient. The specific foods consumed also matter.
Whether this evolutionary model ultimately proves correct remains a subject of scientific debate. However, it provides the conceptual foundation for the clinical work published by Zsófia Clemens and colleagues and helps explain why they view the Paleo Ketogenic Diet as fundamentally different from both standard ketogenic diets and conventional elimination diets.
What Can We Learn From This Case?
Whether one agrees with the conclusions of the Paleomedicina group or not, this case highlights several important lessons about chronic disease and nutrition.
First, it reminds us that diet may influence far more than body weight. Nutrition affects immune function, intestinal physiology, metabolism, inflammatory signaling, and the complex interaction between the gut and the rest of the body.
Second, the case challenges the assumption that chronic diseases can only be managed through medication. The patient described in the report experienced improvements not only in symptoms, but also in objective markers of disease activity. This suggests that nutritional interventions may have the potential to modify disease processes in ways that deserve further investigation.
Third, the case highlights the importance of looking for underlying mechanisms. The Paleomedicina group focuses on intestinal permeability, while others emphasize the elimination of processed foods, nutritional ketosis, microbiome changes, immune modulation, or metabolic improvements. These mechanisms are not necessarily mutually exclusive, and future research may reveal that several are contributing simultaneously.
Perhaps the most important lesson is that a single case report cannot establish a universal treatment, but it can challenge existing assumptions and generate new scientific questions.
The history of medicine contains many examples where important discoveries began with careful observation of unusual clinical outcomes. The purpose of a case report is not to provide final answers, but to identify observations worthy of deeper study.
In the case of this Crohn's disease patient, the observation was remarkable enough to generate ongoing interest years after publication.
The question is no longer whether the patient improved—the report clearly documents that he did.
The question is what caused that improvement, how reproducible it is, and whether the same physiological principles can help other patients with inflammatory bowel disease.
Those are the questions that future research will need to answer.
How Lab Testing Can Help Track Progress in Crohn's Disease
One of the most valuable aspects of the Crohn's disease case reported by the Paleomedicina group is that the improvement was not judged solely by symptoms.
Many patients with inflammatory bowel disease experience periods where symptoms improve while underlying inflammation persists. For this reason, objective markers are essential when evaluating any therapeutic intervention, including dietary approaches.
Inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) can provide insight into systemic inflammation. While not specific to Crohn's disease, changes in these markers may help track disease activity over time.
Nutritional status is equally important. Active Crohn's disease can affect nutrient absorption and increase the risk of deficiencies. Monitoring markers such as:
Complete blood count (CBC)
Iron studies
Vitamin B12
Folate
Vitamin D
Albumin
can help evaluate both disease burden and overall nutritional health.
From a metabolic perspective, some patients may also benefit from tracking:
Fasting glucose
Fasting insulin
Lipid markers
Liver enzymes
particularly when dietary interventions are being used as part of a broader metabolic health strategy.
One interesting aspect of the Paleomedicina report was the use of intestinal permeability testing. The authors reported normalization of a PEG 400 permeability test alongside clinical remission and improvement in objective disease markers. While permeability testing is not routinely used in standard gastroenterology practice, it remains a central component of the group's hypothesis regarding disease mechanisms.
The key point is that meaningful improvement should be measured through more than symptoms alone. Laboratory markers, imaging studies, endoscopy findings, and nutritional assessments provide a more complete picture of what is happening beneath the surface.
Conclusion
The Crohn's disease case reported by Zsófia Clemens and colleagues remains one of the most discussed examples of the Paleo Ketogenic Diet in clinical practice.
The report described a young patient with severe Crohn's disease who experienced symptom resolution, normalization of laboratory markers, improvement in imaging findings, and normalization of an intestinal permeability test while following a strict Paleo Ketogenic Diet. These outcomes allowed the patient to discontinue medication and maintain remission throughout the period described in the publication.
What makes this case particularly interesting is not only the clinical outcome, but the hypothesis behind it.
The Paleomedicina group proposes that chronic diseases such as Crohn's disease may be driven, at least in part, by disruption of the intestinal barrier and ongoing exposure to foods that are not aligned with human physiology. Their therapeutic strategy focuses on restoring normal physiology through a species-appropriate, animal-based ketogenic diet.
Whether this hypothesis ultimately proves correct remains an open scientific question. The published findings are compelling, but they come primarily from case reports and observational data. Larger controlled studies will be needed to determine how broadly these results apply and which mechanisms are responsible for the improvements observed.
What cannot be ignored is that this case challenges conventional assumptions about the role of nutrition in chronic disease. It serves as a reminder that food may influence far more than calories, body weight, or blood sugar. Nutrition has the potential to affect intestinal barrier function, immune regulation, inflammation, and metabolic health in ways that are still being explored.
For patients with Crohn's disease and other chronic inflammatory conditions, the report highlights the importance of asking deeper questions about the relationship between diet and disease rather than assuming that symptom management is the only possible goal.
At QuickLab Mobile, we help patients track objective markers of inflammation, nutritional status, metabolic health, and overall wellness through at-home lab testing in Miami, providing data that can help guide informed decisions about dietary and lifestyle interventions.
👉 Book Your Test Now
Disclaimer:
The information provided in this blog, podcast, and associated content is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. The content shared is based on reputable sources, medical literature, and expert insights, but it should not be used as a replacement for direct consultation with a licensed healthcare provider.
No Doctor-Patient Relationship: Engaging with this content does not create a doctor-patient relationship between you and QuickLabMobile or any contributors. Always consult with a qualified physician, specialist, or healthcare professional before making any medical decisions, changing your treatment plan, or starting/stopping any medications.
Not a Substitute for Medical Advice: While we strive to provide accurate and up-to-date information, medicine is constantly evolving. New research, treatments, and medical recommendations may emerge, and individual health conditions can vary. Do not rely solely on this content for health decisions. If you are experiencing symptoms, have concerns about your health, or require medical assistance, seek immediate care from a licensed medical professional.
Emergency Situations: If you are experiencing a medical emergency, such as difficulty breathing, chest pain, signs of a stroke, or any other life-threatening condition, call 911 (or your local emergency services) immediately. Do not delay seeking emergency care based on information provided here.
Liability Disclaimer: QuickLabMobile, its contributors, and any associated entities do not assume liability for any damages, harm, or adverse outcomes resulting from the use, interpretation, or misuse of the information provided in this content. You are responsible for your own healthcare decisions and should always verify information with a trusted medical professional.
External Links & References: This content may include links to external sources, medical studies, or third-party websites for further reading. These links are provided for convenience and informational purposes only. QuickLabMobile does not endorse, control, or take responsibility for the accuracy of external content. Always verify information with authoritative sources such as the CDC, NIH, WHO.
Final Note: Your health is unique, and what works for one person may not be suitable for another. Stay informed, ask questions, and always prioritize professional medical guidance
